256 related articles for article (PubMed ID: 8968650)
1. Factors which can make patients difficult to treat.
Kane JM
Br J Psychiatry Suppl; 1996 Dec; (31):10-4. PubMed ID: 8968650
[No Abstract] [Full Text] [Related]
2. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
[No Abstract] [Full Text] [Related]
3. Management of treatment refractory schizophrenia.
Morrison DP
Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
[No Abstract] [Full Text] [Related]
4. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease].
Naber D; Lambert M; Karow A
Psychiatr Prax; 2004 Nov; 31 Suppl 2():S230-2. PubMed ID: 15586315
[TBL] [Abstract][Full Text] [Related]
5. [Can psycho-education of chronic schizophrenic patients have a short-term effect on drug-related attitude and behavior?].
Hornung WP; Franzen U; Lemke R; Wiesemann C; Buchkremer G
Psychiatr Prax; 1993 Jul; 20(4):152-4. PubMed ID: 8103230
[TBL] [Abstract][Full Text] [Related]
6. Partial response to antipsychotic treatment: the patient with enduring symptoms.
Emsley RA
J Clin Psychiatry; 1999; 60 Suppl 23():10-3. PubMed ID: 10625194
[TBL] [Abstract][Full Text] [Related]
7. [Deficit schizophrenias].
Puech AJ
Encephale; 1996 Jun; 22 Spec No 2():1. PubMed ID: 8767033
[No Abstract] [Full Text] [Related]
8. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
Buis C; Gourion D; Vaiva G
Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
[No Abstract] [Full Text] [Related]
9. Biological determinants of difficult to treat patients with schizophrenia.
Sharma T; Kerwin R
Br J Psychiatry Suppl; 1996 Dec; (31):5-9. PubMed ID: 8968649
[No Abstract] [Full Text] [Related]
10. [The problem of drug compliance in schizophrenic patients].
Albus M
Psychiatr Prax; 1995 Nov; 22(6):221-2. PubMed ID: 8570750
[No Abstract] [Full Text] [Related]
11. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
[TBL] [Abstract][Full Text] [Related]
12. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
[TBL] [Abstract][Full Text] [Related]
13. [Clozapine and treatment of negative symptoms].
Lançon C; Farisse J; Llorca PM
Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic treatment with neuroleptics. I: State of research on mechanisms of action, effectiveness and compliance in treatment of psychoses].
Krausz M; Sorgenfrei T
Psychiatr Prax; 1991 Jan; 18(1):9-13. PubMed ID: 1674156
[TBL] [Abstract][Full Text] [Related]
15. [Problems in evaluating new antipsychotic drugs].
Fleischhacker WW
Wien Med Wochenschr; 1998; 148(11-12):266-72. PubMed ID: 9746969
[TBL] [Abstract][Full Text] [Related]
16. Do negative symptoms respond to pharmacological treatment?
Kane JM; Mayerhoff D
Br J Psychiatry Suppl; 1989 Nov; (7):115-8. PubMed ID: 2575914
[No Abstract] [Full Text] [Related]
17. [Patient modified medication: how do schizophrenic patients manage their neuroleptics?].
Hornung WP; Buchkremer G; Redbrake M; Klingberg S
Nervenarzt; 1993 Jul; 64(7):434-9. PubMed ID: 8103569
[TBL] [Abstract][Full Text] [Related]
18. Strategies for dosing and switching antipsychotics for optimal clinical management.
Buckley PF; Correll CU
J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
[TBL] [Abstract][Full Text] [Related]
19. Relapse prevention and recovery in the treatment of schizophrenia.
Schooler NR
J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
[TBL] [Abstract][Full Text] [Related]
20. Apomorphine's antipsychotic activity.
Schaffer MH; Davis JM; Tamminga CA
Arch Gen Psychiatry; 1985 Sep; 42(9):927-8. PubMed ID: 2864035
[No Abstract] [Full Text] [Related]
[Next] [New Search]